Form 8-K - Current report:
SEC Accession No. 0001599298-25-000034
Filing Date
2025-01-13
Accepted
2025-01-13 08:37:56
Documents
45
Period of Report
2025-01-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K smmt-20250113.htm   iXBRL 8-K 32660
2 EX-99.1 jpm2025final_8-k.htm EX-99.1 47194
7 GRAPHIC jpm2025final_8-k001.jpg GRAPHIC 66206
8 GRAPHIC jpm2025final_8-k002.jpg GRAPHIC 280154
9 GRAPHIC jpm2025final_8-k003.jpg GRAPHIC 78497
10 GRAPHIC jpm2025final_8-k004.jpg GRAPHIC 82594
11 GRAPHIC jpm2025final_8-k005.jpg GRAPHIC 133149
12 GRAPHIC jpm2025final_8-k006.jpg GRAPHIC 94677
13 GRAPHIC jpm2025final_8-k007.jpg GRAPHIC 47639
14 GRAPHIC jpm2025final_8-k008.jpg GRAPHIC 128286
15 GRAPHIC jpm2025final_8-k009.jpg GRAPHIC 81994
16 GRAPHIC jpm2025final_8-k010.jpg GRAPHIC 150797
17 GRAPHIC jpm2025final_8-k011.jpg GRAPHIC 124423
18 GRAPHIC jpm2025final_8-k012.jpg GRAPHIC 122410
19 GRAPHIC jpm2025final_8-k013.jpg GRAPHIC 136848
20 GRAPHIC jpm2025final_8-k014.jpg GRAPHIC 121041
21 GRAPHIC jpm2025final_8-k015.jpg GRAPHIC 117818
22 GRAPHIC jpm2025final_8-k016.jpg GRAPHIC 135435
23 GRAPHIC jpm2025final_8-k017.jpg GRAPHIC 118833
24 GRAPHIC jpm2025final_8-k018.jpg GRAPHIC 124672
25 GRAPHIC jpm2025final_8-k019.jpg GRAPHIC 145020
26 GRAPHIC jpm2025final_8-k020.jpg GRAPHIC 106781
27 GRAPHIC jpm2025final_8-k021.jpg GRAPHIC 136474
28 GRAPHIC jpm2025final_8-k022.jpg GRAPHIC 122125
29 GRAPHIC jpm2025final_8-k023.jpg GRAPHIC 101815
30 GRAPHIC jpm2025final_8-k024.jpg GRAPHIC 123701
31 GRAPHIC jpm2025final_8-k025.jpg GRAPHIC 117033
32 GRAPHIC jpm2025final_8-k026.jpg GRAPHIC 125817
33 GRAPHIC jpm2025final_8-k027.jpg GRAPHIC 120196
34 GRAPHIC jpm2025final_8-k028.jpg GRAPHIC 125271
35 GRAPHIC jpm2025final_8-k029.jpg GRAPHIC 78578
36 GRAPHIC jpm2025final_8-k030.jpg GRAPHIC 99214
  Complete submission text file 0001599298-25-000034.txt   5139108

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT smmt-20250113.xsd EX-101.SCH 2042
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT smmt-20250113_def.xml EX-101.DEF 14787
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT smmt-20250113_lab.xml EX-101.LAB 26043
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT smmt-20250113_pre.xml EX-101.PRE 15429
47 EXTRACTED XBRL INSTANCE DOCUMENT smmt-20250113_htm.xml XML 3344
Mailing Address 601 BRICKELL KEY DRIVE SUITE 1000 MIAMI FL 33131
Business Address 601 BRICKELL KEY DRIVE SUITE 1000 MIAMI FL 33131 305-203-2034
Summit Therapeutics Inc. (Filer) CIK: 0001599298 (see all company filings)

EIN.: 371979717 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36866 | Film No.: 25525001
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)